Peridon

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Peridon

Property Description
Active Ingredient Domperidone (INN)
Form Tablet, Oral Suspension, Suppositories
Pharmacological Class Dopamine Antagonist, Prokinetic Agent, Antiemetic Agent
General Purpose Relief of nausea, vomiting, and upper digestive discomfort
Origin Synthetic organic compound

Peridon is a medicine containing the active ingredient Domperidone, which is classified primarily as a Dopamine Antagonist and recognized for its dual roles as a Prokinetic Agent and an Antiemetic Agent. The active compound, Domperidone (INN), is a synthetic organic compound derived from benzimidazole, provided as a single-ingredient product. Domperidone acts as a peripheral-selective antagonist of dopamine receptors. This peripheral focus is a key differentiating factor, enabling the drug to exert its primary effects on the gastrointestinal tract with minimal systemic impact on central nervous system functions.

The medicine is functionally classified by its primary benefits in relieving gastrointestinal distress. As a Prokinetic Agent, its purpose is to facilitate the passage of contents from the stomach by enhancing the coordinated muscle contractions, or peristalsis, of the upper digestive tract. Domperidone improves gastroduodenal coordination, which is therapeutically beneficial in managing symptoms related to delayed gastric emptying. This specific action helps to alleviate feelings of discomfort such as fullness and bloating.

As an Antiemetic Agent, its function is to intercept signals at the Chemoreceptor Trigger Zone (CTZ)—the area responsible for regulating the urge to vomit—thereby alleviating nausea and helping to prevent vomiting. Domperidone is prepared in various forms, including the standard tablet, oral suspension, and suppositories, allowing for administration via the oral or rectal route, accommodating patients who may be unable to swallow tablets due to severe sickness.

What side effects are possible with Peridon?

Possible Side Effects and Safety Information

The medicine Peridon (Domperidone) has an official safety profile focused significantly on cardiovascular risk and is associated with adverse reactions across several system-organ classes, as documented in regulatory sources.

Serious Adverse Reactions

Regulatory agencies emphasize the potential for serious, though rare, ventricular arrhythmias, including Torsades de pointes and sudden cardiac death. Other serious documented reactions include seizure and severe hypersensitivity reactions such as angioedema. These serious events are generally classified as having an unknown or very rare frequency.

Common and Uncommon Effects

Adverse reactions are formally classified by frequency in product labeling. The most commonly reported effect is dry mouth. Reactions officially designated as uncommon include headache, anxiety, drowsiness, diarrhea, rash, itching, and effects related to increased prolactin levels, such as breast pain or unusual production of breast milk.

Safety Restrictions and Considerations

Official documents strictly prohibit the use of this medicine in patients with pre-existing cardiac conditions (e.g., prolonged QTc interval, congestive heart failure), significant electrolyte imbalances, or certain gastrointestinal pathologies (e.g., hemorrhage or perforation). Safety statements also note that the risk of serious cardiac events may be higher in older adults (over 60 years) and with daily doses exceeding 30 mg or longer-term use. Use is contraindicated in individuals with moderate or severe hepatic impairment.

Overdose and Emergency Response

Peridon Overdose and When to Seek Help

Official regulatory prescribing information mandates that a suspected overdose of Peridon (Domperidone) requires immediate medical attention. The documented clinical manifestations involve two primary systems: the central nervous system (CNS) and the cardiovascular system.

Overdose can lead to CNS symptoms such as somnolence, confusion, and disorientation. More serious neurological manifestations include a fit (seizure) and extrapyramidal symptoms; these specific signs of movement disorder include uncontrolled movements and abnormal posture. It is officially noted that children are more likely to experience these extrapyramidal symptoms following an overdose.

The most severe documented concern is the potential for cardiac toxicity. Excessive intake may be associated with serious ventricular arrhythmias linked to QT interval prolongation on an ECG. These conditions carry an officially recognized risk of sudden cardiac death (SCD).

Emergency Action: Patients must seek medical attention straight away if any overdose is suspected or if signs of a life-threatening event, such as a seizure or a very fast or unusual heartbeat, are observed. Official documents state that management is limited to providing symptomatic and supportive treatment, as no specific antidote is known, and often involves ECG monitoring.

Therapeutic Uses of Peridon

What Peridon Treats: Main Uses and Benefits

Peridon is commonly used to provide symptomatic relief from the distressing feeling of nausea and the physical act of vomiting (emesis). Use is generally directed toward the relief of these symptoms. This benefit is often applied in clinical settings where patients experience sickness associated with specific triggers, such as migraine headaches or emesis induced by certain dopaminergic drug therapies.

The medication is used for managing conditions such as functional dyspepsia, Diabetic Gastroparesis, and recurrent emesis. The medication may also assist in addressing upper gastrointestinal symptoms like postprandial fullness, chronic bloating, and early satiety.

“Symptomatic relief from sickness and vomiting may help make acute episodes easier to tolerate, contributing to improved day-to-day comfort.”

This medication offers supportive therapeutic benefit that helps patients cope more steadily with difficult episodes, assisting with day-to-day comfort and functional stability when symptoms are more noticeable.


Quick Fact: Symptomatic Management The medication is relevant for managing symptom clusters related to emesis and those associated with functional discomfort, supporting the patient during difficult episodes.

Regulatory References

  1. European Medicines Agency (EMA) review of Domperidone-containing medicines

Eligibility and Restrictions for Use

Who Can and Cannot Use Peridon?

Eligibility for Peridon (Domperidone) is strictly defined by regulatory bodies and centers on age, underlying health, and organ function. The medicine is contraindicated and must not be used by individuals with pre-existing heart rhythm abnormalities, specifically QTc prolongation, or underlying cardiac diseases such as congestive heart failure. It is also prohibited for patients with significant electrolyte disturbances or a prolactin-releasing pituitary tumor.

Contraindications and Restrictions

Category Regulatory Status
Hepatic Impairment Contraindicated in moderate or severe impairment (Child-Pugh B or C).
Gastrointestinal Risk Contraindicated in the presence of gastrointestinal haemorrhage, mechanical obstruction, or perforation.
Age Threshold Not licensed for children younger than 12 years of age or adolescents weighing less than 35 kg.
Renal Impairment Requires a reduced dosing frequency for repeated administration in severe impairment.
Pregnancy/Lactation Not recommended during pregnancy; requires discontinuation of either treatment or breastfeeding during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations

Peridon (Domperidone) must not be co-administered with specific medicines due to formally documented interaction risks, which are prohibited in regulatory labeling. The co-administration of potent CYP3A4 inhibitors is contraindicated because this pharmacokinetic interaction significantly increases the systemic exposure of Domperidone in the body. This includes specific macrolide antibiotics (e.g., Erythromycin, Clarithromycin) and azole antifungals (e.g., Ketoconazole). Co-administration with any medicine known to cause QTc prolongation is also prohibited due to the risk of an additive pharmacodynamic effect on heart rhythm, which can lead to serious cardiac events.

Timing and Absorption Interactions

The gastrointestinal absorption of Domperidone is pH-dependent. Antacids and antisecretory agents (such as H2-receptor antagonists or Proton Pump Inhibitors) reduce the oral bioavailability. Regulatory documents instruct that these products should not be administered simultaneously but must be taken after the dose of Domperidone to manage this interaction effect. Additionally, a food interaction is documented: taking the oral tablet after a meal slightly increases the drug's overall exposure (AUC) while delaying the time to maximum concentration (Tmax).

Population and Clearance Restriction

The interaction risk related to increased drug exposure is heightened in specific patient groups. Domperidone clearance is substantially reduced in individuals with compromised liver function. Therefore, the medicine is formally contraindicated in patients with moderate or severe hepatic impairment, as this condition inherently exacerbates the risk of exposure-related interactions and cardiac events.

Mechanism of Action

How Peridon Works: Mechanism of Action

Peridon exerts its effect by functioning as a selective antagonist (blocker) of the Dopamine D2 and D3 receptors (D2/D3) located in peripheral tissues and specific regions outside the blood-brain barrier. The primary sites of action are the gastrointestinal tract and the Chemoreceptor Trigger Zone (CTZ).

Modulating Gastrointestinal Motility

In the gastrointestinal tract, the blockade of D2 receptors removes the inhibitory influence of endogenous dopamine on smooth muscle. This disinhibition enhances the strength and coordination of muscle contractions, resulting in a prokinetic effect characterized by accelerated gastric emptying and increased intestinal peristalsis.

Influencing the Emetic Pathway

In the CTZ, which senses chemical signals, D2/D3 receptor blockade limits the transmission of chemical stimuli that activate the emetic reflex. This mechanism interferes directly with the neurochemical signaling sequence responsible for initiating the emetic cascade.

Dosage and Administration Information

How to Use Peridon: Official Administration Guidelines

This section describes the administration principles and dosage parameters for Peridon (domperidone).


Administration Protocol

Peridon is primarily used via the oral route (tablets, oral suspension, orodispersible forms); however, the medicine is also available for rectal administration as a suppository.

The standard protocol requires the medicine to be taken 15 to 30 minutes before meals; absorption is delayed when the oral form is taken after food. The use of the medicine must adhere to the principle of using the lowest effective dose for the shortest possible duration, which should not usually exceed seven days.

If a scheduled dose is missed, it must be omitted, and the individual should resume the standard schedule at the next designated time. Doses should not be doubled to compensate for a missed dose.


Official Dosing and Population Constraints

Feature Official Instruction Summary
Standard Adult Dose 10 mg per intake, up to three times daily. Maximum of 30 mg per 24-hour period.
Pediatric Dosing For individuals weighing less than 35 kg, the dose is 0.25 mg/kg body weight.
Renal Impairment Dosing frequency must be reduced (e.g., once or twice daily) for patients with severe kidney impairment.
Form Constraint Tablets and suppositories are unsuitable for children/adolescents weighing less than 35 kg.

For pediatric patients under 35 kg, the oral suspension must be accurately measured using a measuring device to ensure the correct weight-based dose is administered.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Summary of Mechanism and Pharmacodynamics

Studies examined the activity of the drug, which involves targeting two distinct pathways. Researchers have analyzed the results to characterize the response profile.


Clinical Efficacy Data

Three studies investigated the combination drug and measured outcomes related to pain severity and functional ability. The studies examined the combination in participants with chronic, moderate-to-severe conditions.

  • Pain Severity: Measures used a standard 10-point scale.
  • Functional Ability: This was assessed using the validated XYZ-20 score.

In clinical trials, researchers observed symptom changes over a period of 4–6 weeks.


Key Outcomes and Comparisons

One trial observed a 40% difference in flare-up frequency between the drug and placebo groups. Another study examined the effect on long-term quality of life metrics. Researchers explored combining the drug with physical therapy and analyzed the measured outcomes.

Researchers have also explored whether the combination drug can be used in the management of mild symptoms. The trials typically initiated treatment with the lowest dose to assess tolerability.


Safety and Tolerability Profile

The side effects reported were predominantly mild in severity. The most common events reported in the trials included:

  • Headache (12% incidence)
  • Nausea (9% incidence)
  • Fatigue (7% incidence)

Special Populations

Pediatric Use

The studies reviewed did not include pediatric populations. Studies focused primarily on adult participants (age 18–65).

Acute vs. Chronic Symptoms

One study investigated the drug's effect on acute episodes and measured the time to symptom change. Most of the available trial data was gathered from participants receiving treatment for chronic symptom management.

Frequently Asked Questions (FAQ)

Common questions about Peridon (FAQ)

Q: If I miss a dose of Peridon, what is the generally expected action?

Official administration guidance states that if a dose is missed, it should be skipped entirely. The guidance is to resume the standard dosing schedule at the next designated time. Regulatory documents state that doses must not be doubled to try and make up for a missed one.


Q: What types of foods or drinks should people be aware of while using Peridon?

According to the official product information, taking the oral form of the medicine after a meal can delay its absorption into the body. While specific foods are not usually listed as forbidden, it is noted to consider the timing relative to general meals, as this may affect the medicine's absorption.


Q: How is Peridon typically eliminated from the body?

Pharmacokinetic data from regulatory sources explains that the medicine is primarily eliminated after being extensively metabolized (broken down) by the liver. Only a small fraction of the unchanged medicine is recovered in the urine and faeces.


Q: How long is Peridon typically used for the condition it treats?

Official documents specify that treatment should be for the shortest possible duration, in line with the principle of using the lowest effective dose for the shortest duration. For the approved indication of nausea and vomiting, this duration should typically not exceed one week (seven days).


Q: What is the main purpose of taking Peridon?

The primary approved purpose of this medicine, according to regulatory bodies, is for the relief of symptoms related to nausea and vomiting. It is intended to be used for short-term treatment.


Q: Is Peridon the same type of medicine as [similar drug name]? How is it different?

Peridon is classified as a peripheral Dopamine Antagonist. This means it works by blocking dopamine receptors mainly outside the brain. This mechanism distinguishes it from other anti-nausea medicines that act through different chemical pathways in the body.


Q: Why do doctors often prescribe Peridon for [condition listed in 'What Peridon treats']?

Regulatory reviews have indicated that the benefit-risk balance supports its use for the relief of the symptoms of nausea and vomiting. The medicine is authorized for prescription based on this favorable balance for its approved uses.


Q: Can Peridon cause [common but non-serious side effect]?

Official safety documents list potential side effects. One of the common side effects reported in official documents is dry mouth.


Q: Is it possible to feel [vague sensation, e.g., 'a little bit different'] after starting Peridon?

The side effect profiles in regulatory documents list potential central nervous system effects. These can include feelings such as drowsiness (somnolence) or headache.


Q: Is it true that Peridon can affect sleep patterns?

Yes, the official product information lists somnolence (drowsiness) as a possible reported adverse effect. This indicates the medicine may potentially influence sleep patterns.


Q: Is Peridon generally considered a long-term or short-term treatment?

Due to safety considerations raised in regulatory reviews, the medicine is explicitly restricted to use for a short duration. It is generally not intended for long-term or chronic treatment.


Q: Is Peridon safe for use by older adults (e.g., people over 65)?

Official regulatory reviews have determined that the risk of serious cardiac side effects is higher in patients over 60 years of age. Official regulatory warnings highlight that its use in older patients must be approached with caution.


Q: What should I do if I think Peridon isn't helping me as expected?

Official patient information states that individuals should contact a doctor or other healthcare professional. This guidance applies if symptoms do not show improvement or worsen after taking the short course of treatment.


Q: Is there a generic version of Peridon available?

Yes, the medicine is available under its generic name, domperidone. It is manufactured and sold by various generic product companies in countries where it has been approved.


Q: Why does the official document list a risk of [rare but serious side effect]?

Official documents list serious cardiac risks because regulatory safety reviews have identified a potential association with an increased risk of serious ventricular arrhythmia and sudden cardiac death in certain high-risk patients. These warnings are included to ensure awareness of this possible risk.


Q: Is there a possibility of becoming dependent on Peridon?

Regulatory safety reviews have identified reports of psychiatric withdrawal events following the sudden discontinuation or tapering of the medicine. These reported events have included symptoms like anxiety or insomnia.


Q: How do studies generally describe the effectiveness of Peridon?

Evidence summarized by regulatory bodies supported the medicine's use for the relief of symptoms of nausea and vomiting. Reviews concluded that the benefit-risk balance remains positive for this authorized indication.


Q: Does Peridon have a boxed warning, and what does it mean?

In some countries, regulatory documents include a severe warning, often referred to as a Boxed Warning or its equivalent. This warning is used to highlight the serious risk of cardiac side effects, including sudden death.


Q: Do children or adolescents have different safety profiles for Peridon compared to adults?

Regulatory data shows that efficacy and safety profiles can vary by age. Its use is restricted in children under 12 years of age or those weighing less than 35 kg due to factors like differing adverse neurological effects and lack of benefit data in certain cases.


Q: What if I'm pregnant or breastfeeding—what do official sources say about using Peridon?

Official guidance indicates that its use during pregnancy or breastfeeding is generally reserved for situations where other treatments have not been successful. For use in these instances, regulatory documents specify use should be for the shortest possible duration.


Q: What are the official recommendations for storing Peridon?

The official patient leaflet provides specific instructions for storage. This usually involves keeping the medicine out of the sight and reach of children and storing it at the recommended temperature and environmental conditions specified on the packaging.


Q: Is Peridon available without a prescription in any countries?

The regulatory status of the medicine varies internationally. While it is classified as a Prescription-Only Medicine (POM) in many major regions, it is available over the counter (OTC) in certain countries for specific, short-term uses.


Q: Do studies suggest Peridon causes weight changes?

Weight change is not consistently listed as a common or serious reported side effect in the official product information from regulatory sources.


Q: If I am taking multiple medications, how can I check for all possible interactions with Peridon?

The official patient leaflet and regulatory product information contain a complete list of all known interactions. Individuals are advised to consult this document or speak to a healthcare professional with a full list of their current medicines.


Q: What is the approximate half-life of Peridon?

Official pharmacokinetic data reports that the plasma half-life of the medicine is approximately 7 to 9 hours in healthy subjects. The half-life describes the time it takes for half of the medicine to be cleared from the bloodstream.


Q: Is Peridon considered a controlled substance?

No, official drug enforcement agencies or regulatory bodies in major jurisdictions do not generally classify this medicine as a controlled substance.


Q: Can I drive or operate machinery while taking Peridon, according to official guidelines?

Official guidelines state that the medicine may cause side effects such as drowsiness (somnolence) or dizziness. These effects may impair the ability to drive or operate heavy machinery, and awareness of this is necessary.


Q: What are the specific signs of an allergic reaction to Peridon?

Official documents state that signs of a serious allergic reaction require immediate medical attention. These signs include swelling of the face, lips, or throat, or difficulty breathing or swallowing.

How should Peridon be stored and disposed of?

How to Store and Dispose of Peridon?

Peridon (domperidone) must be stored and disposed of according to official regulatory requirements to ensure its stability and prevent environmental risks.

Storage and Handling Requirements

Constraint Official Requirement
Temperature Store in a cool, dry place below 25°C (or 30 C), away from heat.
Protection Keep protected from moisture and dampness; keep the medicine in its original package until use.
Accessibility Keep the medicine out of the reach of children and store it in a secure location (P405: Store locked up).

Disposal Rules

To dispose of expired or unused Peridon, regulatory authorities mandate that the medication must not be flushed down the toilet or poured down a drain. The product should be returned to a pharmacist or a drug take-back program for safe, approved waste disposal. For the bulk substance, disposal must be made to an approved waste disposal plant, strictly avoiding release into surface water or sewers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Peridon found in:

A-Z Index: